Table S1.
Definitions | |
Airway obstruction | FEV1/FVC ratio <0.70 |
BD reversibility test | ERS/ATS recommendations: ”Significant” BD response was defined as an increase in FEV1 of minimum 0.200 L and 12% of pre-BD FEV1 after administration of a short-acting β2 agonist30 |
Corticosteroid reversibility test | Six weeks of treatment with inhaled corticosteroid or 14 days of oral steroid followed by repeat spirometry. An increase in FEV1 of >0.200 L was considered a positive test |
COPD | Spirometric defined according to GOLD recommendations 2014: Post-BD FEV1/FVC ratio <0.7016 |
GOLD severity of airway obstruction | FEV1 % predicted: |
GOLD 1: mild | ≥80% |
GOLD 2: moderate | 50%≤ FEV1 <80% |
GOLD 3: severe | 30%≤ FEV1 <50% |
GOLD 4: very severe | <30% |
Asthma | Increase in FEV1 >0.500 L at the BD reversibility test or >0.200–0.500 L with additional 0.200 L increase on the corticosteroid reversibility test |
Abbreviations: ATS, American Thoracic Society; BD, bronchodilator; COPD, chronic obstructive pulmonary disease; ERS, European Respiratory Society; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease.